IL-8 is a novel marker for breast cancer

被引：0
|
作者：
C Chavey
A Freund
S Durand
G Lazennec
机构：
[1] INSERM U540,
来源：
Breast Cancer Research | / 7卷
关键词：
Breast Cancer; Breast Cancer Cell; Breast Cell; Invasion Potential; Cancer Management;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Association of interleukin-8 (IL-8 or CXCL8)-251T/A and CXCR2+1208C/T gene polymorphisms with breast cancer
    Kamali-Sarvestani, E.
    Aliparasti, M. R.
    Atefi, S.
    NEOPLASMA, 2007, 54 (06) : 484 - 489
  • [32] The Association Between IL-8 Gene Polymorphisms and the Risk of Several Types of Cancer, Especially in Gastric Cancer
    Xu, Bin
    Yan, Yidan
    CANCER REPORTS, 2025, 8 (01)
  • [33] MicroRNA-520c-3p negatively regulates EMT by targeting IL-8 to suppress the invasion and migration of breast cancer
    Tang, Cui-Ping
    Zhou, Han-Jing
    Qin, Jian
    Luo, Yi
    Zhang, Tao
    ONCOLOGY REPORTS, 2017, 38 (05) : 3144 - 3152
  • [34] DEK: A novel early screening and prognostic marker for breast cancer
    Ying, Guo
    Wu, Yonghui
    MOLECULAR MEDICINE REPORTS, 2015, 12 (05) : 7491 - 7495
  • [35] The prognostic role of interleukin-8 (IL-8) and matrix metalloproteinases-2 and-9 in lymph node-negative untreated breast cancer patients
    Milovanovic, J.
    Todorovic-Rakovic, N.
    Abu Rabi, Z.
    JOURNAL OF BUON, 2013, 18 (04): : 866 - 873
  • [36] Homotypic Entosis as a Potential Novel Diagnostic Marker in Breast Cancer
    Dziuba, Ireneusz
    Gawel, Agata M.
    Tyrna, Pawel
    Machtyl, Jedrzej
    Olszanecka, Monika
    Pawlik, Andrzej
    Wojcik, Cezary
    Bialy, Lukasz P.
    Mlynarczuk-Bialy, Izabela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (07)
  • [37] Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling
    Zhang, Yueyang
    Zou, Binhua
    Tan, Yanhui
    Su, Jianbing
    Wang, Yiyuan
    Xu, Jialan
    Tao, Lei
    Zhou, Hua
    Liu, Liang
    Li, Xiaojuan
    PHARMACOLOGICAL RESEARCH, 2019, 142 : 140 - 150
  • [38] Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
    Rochanawan Sootichote
    Peti Thuwajit
    Ekapot Singsuksawat
    Malee Warnnissorn
    Pa-thai Yenchitsomanus
    Suthinee Ithimakin
    Jomjit Chantharasamee
    Chanitra Thuwajit
    BMC Cancer, 18
  • [39] Compound A attenuates toll-like receptor 4-mediated paclitaxel resistance in breast cancer and melanoma through suppression of IL-8
    Sootichote, Rochanawan
    Thuwajit, Peti
    Singsuksawat, Ekapot
    Warnnissorn, Malee
    Yenchitsomanus, Pa-thai
    Ithimakin, Suthinee
    Chantharasamee, Jomjit
    Thuwajit, Chanitra
    BMC CANCER, 2018, 18
  • [40] FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer
    Fu, Xiaoyong
    Jeselsohn, Rinath
    Pereira, Resel
    Hollingsworth, Emporia F.
    Creighton, Chad J.
    Li, Fugen
    Shea, Martin
    Nardone, Agostina
    De Angelis, Carmine
    Heiser, Laura M.
    Anur, Pavana
    Wang, Nicholas
    Grasso, Catherine S.
    Spellman, Paul T.
    Griffith, Obi L.
    Tsimelzon, Anna
    Gutierrez, Carolina
    Huang, Shixia
    Edwards, Dean P.
    Trivedi, Meghana V.
    Rimawi, Mothaffar F.
    Lopez-Terrada, Dolores
    Hilsenbeck, Susan G.
    Gray, Joe W.
    Brown, Myles
    Osborne, C. Kent
    Schiff, Rachel
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2016, 113 (43) : E6600 - E6609
12345